{"filing":{"accession_number":"0001213900-26-079416","cik":"0001734005","ticker":"APM","company_name":"Niki BioSolutions, Inc.","form":"8-K","filing_date":"2026-07-20","report_date":null,"primary_document":"ea0298262-8k_nikibio.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1734005/000121390026079416/ea0298262-8k_nikibio.htm"},"events":[{"id":18702,"run_id":16821,"accession_number":"0001213900-26-079416","anchor_item_number":"2.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.97,"summary":"Aptorum Group Limited completed its merger with DiamiR Biosciences Corp. on July 20, 2026, with the combined entity domesticated to Delaware and renamed Niki BioSolutions, Inc., trading under ticker 'NIKI'. The transaction involved the issuance of shares to both Aptorum and DiamiR shareholders, constituting a material change of control and business combination.","company_name":"Niki BioSolutions, Inc.","ticker":"APM","filing_date":"2026-07-20","form":"8-K","submitted_at":null,"items":[{"id":17590,"accession_number":"0001213900-26-079416","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the completion of a merger between Aptorum Group Limited and DiamiR Biosciences Corp. on July 20, 2026. Item 2.01 explicitly states: \"Aptorum consummated its previously announced merger (the 'Closing') pursuant to that certain Agreement and Plan of Merger on July 14, 2025.\" The transaction involved a domestication of Aptorum to Delaware, a name change to Niki BioSolutions, Inc., and the issuance of shares to both Aptorum and DiamiR shareholders. This is a material acquisition/merger activity that fundamentally changes the registrant's structure and ownership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:10.247875+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17591,"accession_number":"0001213900-26-079416","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses the closing of a merger between Aptorum Group Limited and DiamiR Biosciences Corp., with the combined entity renamed Niki BioSolutions, Inc. trading under ticker \"NIKI\" effective July 20, 2026. Item 5.03 references Items 2.01 and 3.03, which typically cover material acquisitions and changes of control. The press release confirms the merger closed on or about July 20, 2026, constituting a material change of control and business combination.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:10.247875+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17590,"accession_number":"0001213900-26-079416","item_number":"2.01","item_title":"Completion of Acquisition or Disposition","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the completion of a merger between Aptorum Group Limited and DiamiR Biosciences Corp. on July 20, 2026. Item 2.01 explicitly states: \"Aptorum consummated its previously announced merger (the 'Closing') pursuant to that certain Agreement and Plan of Merger on July 14, 2025.\" The transaction involved a domestication of Aptorum to Delaware, a name change to Niki BioSolutions, Inc., and the issuance of shares to both Aptorum and DiamiR shareholders. This is a material acquisition/merger activity that fundamentally changes the registrant's structure and ownership.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:10.247875+00:00","company_name":"Niki BioSolutions, Inc.","ticker":"APM","filing_date":"2026-07-20"},{"id":17591,"accession_number":"0001213900-26-079416","item_number":"5.03","item_title":"Amendments to Articles of Incorporation","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses the closing of a merger between Aptorum Group Limited and DiamiR Biosciences Corp., with the combined entity renamed Niki BioSolutions, Inc. trading under ticker \"NIKI\" effective July 20, 2026. Item 5.03 references Items 2.01 and 3.03, which typically cover material acquisitions and changes of control. The press release confirms the merger closed on or about July 20, 2026, constituting a material change of control and business combination.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T13:17:10.247875+00:00","company_name":"Niki BioSolutions, Inc.","ticker":"APM","filing_date":"2026-07-20"}]}